Clinical Trials: Rethinking How We Ensure Quality

View / Download189.51 KB

Date

2012-11-01

Authors

Journal Title

Journal ISSN

Volume Title

Citation Stats

Attention Stats

Abstract

Type

Journal article

Department

Description

This article is the version submitted to the publisher which was accepted without revision.

Provenance

Subjects

Citation

Permalink

https://hdl.handle.net/10161/6095

Published Version (Please cite this version)

10.1177/0092861512464372

Publication Info

Landray, MJ, C Grandinetti, JM Kramer, BW Morrison, L Ball and RE Sherman (2012). Clinical Trials: Rethinking How We Ensure Quality. Drug Information Journal, 46(6). pp. 657–660. 10.1177/0092861512464372 Retrieved from https://hdl.handle.net/10161/6095.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Collections

Scholarly Articles
Full item page

Scholars@Duke

Kramer

Judith Mae Kramer

Professor Emeritus of Medicine

· Studying methods to facilitate the uptake of evidence-based treatment recommendations.
· Optimizing the use of drugs, devices, and biological products in clinical practice.
· Studying methods of risk management for therapeutic products

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.